IMIrina Rudik Miksa

Irina Rudik Miksa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Irina Rudik Miksa has a total of 2 co-authors. Here are the top co-authors by number of shared publications:

  • Robert H. Poppenga

    University of Pennsylvania, School of Veterinary Medicine, Department of Pathobiology, New Bolton Center, Toxicology , 382 West Street Road, Kennett Square, Pennsylvania 19348

    2 shared publications
  • Margaret R. Cummings

    University of Pennsylvania, School of Veterinary Medicine, Department of Pathobiology, New Bolton Center, Toxicology , 382 West Street Road, Kennett Square, Pennsylvania 19348

    1 shared publication

Latest Publications

  • Open Access

    Multi-Residue Determination of Anti-Inflammatory Analgesics in Sera by Liquid Chromatography-Mass Spectrometry

    by Irina Rudik Miksa, Margaret R. Cummings, Robert H. Poppenga

    Non-steroidal anti-inflammatories (NSAIDs) are analgesic, antipyretic, and, as their name implies, anti-inflammatory drugs, which are widely used for the treatment of a variety of human and veterinary disease conditions in which control of pain and inflammation is desired. Acetaminophen (ACE) is a common over-the-counter analgesic. Detection of a variety of widely used NSAIDs and ACE in fluid and tissue samples is an important diagnostic tool. A sensitive and selective analytical method has been developed for simultaneous screening of 12 NSAIDs and ACE by liquid chromatography-mass spectrometry with an atmospheric pressure chemical ionization interface set to operate in the negative ion mode of MS. Following sample preparation, all analytes were separated on a C18-reversed-phase column with a gradient elution of acetonitrile and acetic acid. Full-scan mass spectral fragmentation profiles were established for each analyte and individual extracted ion chromatograms were used for quantitation. Linearity of detection was observed over the 0.05–25.0 µg/mL range of standard concentrations. The instrument limits of detection (LOD), based on an individual analyte quantitation ions, fell between 0.05 and 1.0 µg/mL for all compounds. The matrix LODs were determined to be 0.05 µg/mL for phenylbutazone (m/z 307); 0.1 µg/mL for indomethacin (m/z 312), flunixin (m/z 295), and piroxicam (m/z 330); 0.5 µg/mL for ACE (m/z 150), diclofenac (m/z 250), ketoprofen (m/z 209), and mefenamic acid (m/z 240); 1.0 µg/mL for oxyphenbutazone (m/z 323); 5.0 µg/mL for ibuprofen (m/z 205), salicylic acid (m/z 137), and tolmetin (m/z 212); and 10 µg/mL for naproxen (m/z 185).


  • Open Access

    Direct and Rapid Determination of Baclofen (Lioresal®) and Carisoprodol (Soma®) in Bovine Serum by Liquid Chromatography-Mass Spectrometry

    by Irina Rudik Miksa, Robert H. Poppenga

    Baclofen (Lioresal), a lipophilic analogue of γ-aminobutyric acid (GABA), and carisoprodol (Soma), a central nervous system depressant with an unknown mechanism of pharmacologic action, are categorized as muscle relaxants. Baclofen is used clinically in the management of spasticity and its sequelae secondary to severe chronic disorders such as multiple sclerosis and other types of spinal cord lesions. Carisoprodol is used for discomfort associated with acute and painful musculoskeletal conditions. Intoxication from these drugs occurs in both humans and animals necessitating a need for their detection in plasma/serum, tissue, and gastrointestinal contents samples. A sensitive and specific analytical method for detection and quantitation of these compounds using liquid chromatography with positive atmospheric pressure chemical ionization-mass spectrometry was developed. A rapid extraction procedure for both analytes from fortified bovine sera is described. Chromatographic separation was carried out on a C18 reverse-phase column with a gradient elution of acetonitrile and 0.25% acetic acid. The effluent was directed to the mass spectrometer with fragmentation information for baclofen and carisoprodol obtained in a scan monitoring mode. Linear standard curves for baclofen and carisoprodol were constructed based on at least two corresponding extracted ions over a concentration range of 0.1–50 µg/mL. The analysis of fortified sera samples demonstrates good accuracy and precision for the method with a limit of detection of 0.5 µg/mL for carisoprodol (n = 3) and 1 µg/mL for baclofen (n = 4) and a limit of quantitation of 2 µg/mL for both compounds. Recoveries at the limit of quantitation were between 75 and 95% for both analytes, with a 4.8µ9.3% range in standard deviation.